gastrodin and oxidopamine
gastrodin has been researched along with oxidopamine in 4 studies
Compound Research Comparison
| Studies (gastrodin) | Trials (gastrodin) | Recent Studies (post-2010) (gastrodin) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 302 | 3 | 234 | 8,630 | 6 | 2,407 |
Protein Interaction Comparison
| Protein | Taxonomy | gastrodin (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Haddadi, R; Nadi, F; Poursina, M; Zeraati, F | 1 |
| Dong, HJ; Guo, LP; Li, Y; Liu, DH; Mu, Y; Wang, X; Wang, ZW; Zhou, HL | 1 |
| Cao, X; Li, Z; Yan, J; Yang, Z; Zhao, N | 1 |
| Eyvari-Brooshghalan, S; Haddadi, R; Nourouzi, N; Sabahi, M; Sadeghian, Z | 1 |
Other Studies
4 other study(ies) available for gastrodin and oxidopamine
| Article | Year |
|---|---|
Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc.
Topics: Animals; Benzyl Alcohols; Catalepsy; Glucosides; Lipid Peroxidation; Male; Microglia; Microinjections; Nitric Oxide; Oxidation-Reduction; Oxidopamine; Parkinsonian Disorders; Pars Compacta; Peroxidase; Rats; Rats, Wistar | 2018 |
Four new phenolic constituents from the rhizomes of Gastrodia elata Blume.
Topics: Animals; Benzyl Alcohols; Cell Death; Cell Line; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Gastrodia; Glucosides; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Neurons; Neuroprotective Agents; Oxidopamine; Phenols; Plant Extracts; Rhizome | 2019 |
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Benzyl Alcohols; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Chemotaxis; Dopaminergic Neurons; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Glucosides; Neuroprotection; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptor, Insulin; Signal Transduction | 2019 |
Post treatment with Gastrodin suppresses oxidative stress and attenuates motor disorders following 6-OHDA induced Parkinson disease.
Topics: Animals; Disease Models, Animal; Humans; Motor Disorders; Oxidative Stress; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Peroxidase; Rats; Rats, Wistar; Substantia Nigra | 2022 |